An Open, Prospective Study to Assess the Efficacy and Safety of FK506 Combined MMF in the Treatment of Class III, IV, V + IV or V + III Lupus Nephritis.
Phase of Trial: Phase III
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Tacrolimus (Primary) ; Cyclophosphamide; Mycophenolate mofetil
- Indications Lupus nephritis
- Focus Therapeutic Use
- 25 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 May 2010 Actual patient number (120) added as reported by ClinicalTrials.gov.
- 25 May 2010 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.